Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Bull stationery tab
Cleaning device, and image forming apparatus, process cartridge, and intermediate transfer unit each including the cleaning device
Multiple input multiple output transceiver
People engine optimization
Removable case
Identification wristband
Enhanced telephony services
  Randomly Featured Patents
Work machine
Family of transmission mechanisms with three planetary gear sets and a stationary member
Single connection gas discharge display and driver
Cantilevered sorter
Biocatalytic synthesis of quinic acid and conversion to hydroquinone
Separator for fuel cell
Method and computer program for reconciling, building, and replenishing cash drawers with coins
Shield plate mounting structure for helmet
Container and candle embedded therein
Recreational and utility three or four-wheeled recumbent cycle with on-demand zero emmissions electric motor and multi-geared manual pedal drive